Abstract
Although hormone replacement therapy (HRT) is used by post-menopausal women for the relief of menopausal symptoms and the potential reduction of osteoporosis, HRT also increases their risk of Alzheimer’s disease, stroke, breast cancer, and endometrial cancer. Since the majority of these effects are associated primarily with estrogen binding to only one of the estrogen receptors (ER), new assays are needed that can more efficiently evaluate ER-binding and identify ligands selective for ER-α and ER-β. High performance liquid chromatography-tandem mass spectrometry (LC-MS-MS) was combined with ultrafiltration as a new method to investigate the relative binding of compounds to the ERs and to evaluate the structures of these estrogens. Mixtures of estradiol and six equine estrogens, including equilin, equilenin, 8,9-dehydroestrone, and their 17β-hydroxyl derivatives, were assayed simultaneously to determine their relative binding to human ER-α and ER-β. Estrogens containing a 17β-OH group were found to have higher relative affinities for the estrogen receptors than their ketone analogs. In addition, 17β-EN showed selectivity for binding to ER-β over ER-α. The results were compared to the IC50 values obtained by using a conventional radiolabled estradiol competitive binding assay. Finally, the utility of negative ion electrospray tandem mass spectrometry for the unambiguous identification of these estrogen isomers was investigated. Several characteristic recyclization pathways during tandem mass spectrometry were identified, which might be useful for distinguishing related estrogens.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Gaido, K. W.; Maness, S. C.; Waters, K. M. Exploring the biology and toxicology of estrogen receptor-β. AIIT Activities 1999, 19, 1–5.
Saegusa, M.; Okayasu, I. Changes in expression of estrogen receptors α and β in relation to progesterone receptor and pS2 status in normal and malignant endometrium. Jpn. J. Cancer Res 2000, 91, 510–518.
Kuiper, G. G.; Enmark, E.; Pelto-Huikko, M.; Nilsson, S.; Gustafsson, J.-A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 5925–5930.
Mosselman, S.; Polman, J.; Dijlkema, R. ER-β: Identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996, 392, 49–53.
Brandenberger, A. W.; Tee, M. K.; Lee, J. Y.; Chao, V.; Jaffe, R. B. Tissue distribution of estrogen receptors β (ER-α) and β (ER-β) mRNA in the midgestational human fetus. J. Clin. Endocrinol. Metab. 1997, 82, 3509–3512.
Gustafsson, J.-A. Estrogen receptor β—A new dimension in estrogen mechanism of action. J. Endocrinol. 1999, 163, 370–383.
Brosage, P. Hormone therapy: The woman’s decision. Contemp. Nurse. Pract. 1995, 1(S), 3.
Colditz, G. A.; Hankinson, S. E.; Hunter, D. J.; Willett, W. C.; Manson, J. E.; Stamper, M. J.; Hennekens, C.; Rosner, B.; Speizer, F. E. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. New Engl. J. Med. 1995, 332, 1589–1593.
Grodstein, F.; Stamfer, M. J.; Colditz, G. A.; Willett, W. C.; Manson, J. E.; Joffe, M.; Rosner, B.; Fuchs, C.; Hankinson, S. E.; Hunter, D. J.; Hennekens, C. H.; Speizer, F. E. Postmenopausal hormone therapy and mortality. New Engl. J. Med. 1997, 336, 1769–1775.
Lupulescu, A. Estrogen use and cancer incidence: A review. Cancer Invest. 1995, 13, 287–295.
Bolton, J. L.; Pisha, E.; Zhang, F.; Qiu, S. Role of quinoids in estrogen carcinogenesis. Chem. Res. Toxicol. 1998, 11, 1113–1127.
Liehr, J. G. Is estradiol a genotoxic mutagenic carcinogen? Endocrine Rev. 2000, 21, 40–54.
Anderson, G. L.; Limacher, M.; Assaf, A. R.; Bassford, T.; Beresford, S. A.; Black, H.; Bonds, D.; Brunner, R.; Brzyski, R.; Caan, B.; Chlebowski, R.; Curb, D.; Gass, M.; Hays, J.; Heiss, G.; Hendrix, S.; Howard, B. V.; Hsia, J.; Hubbell, A.; Jackson, R.; Johnson, K. C.; Judd, H.; Kotchen, J. M.; Kuller, L.; LaCroix, A. Z.; Lane, D.; Langer, R. D.; Lasser, N.; Lewis, C. E.; Manson, J.; Margolis, K.; Ockene, J.; O’Sullivan, M. J.; Phillips, L.; Prentice, R. L.; Ritenbaugh, C.; Robbins, J.; Rossouw, J. E.; Sarto, G.; Stefanick, M. L.; Van Horn, L.; Wactawski-Wende, J.; Wallace, R.; Wassertheil-Smoller, S.; Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women’s Health Initiative randomized controlled trial. JAMA 2004, 291, 1701–1712.
Espeland, M. A.; Rapp, S. R.; Shumaker, S. A.; Brunner, R.; Manson, J. E.; Sherwin, B. B.; Hsia, J.; Margolis, K. L.; Hogan, P. E.; Wallace, R.; Dailey, M.; Freeman, R.; Hays, J. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women’s Health Initiative Memory Study. JAMA 2004, 291, 2959–2968.
Lagana, A.; Bacaloni, A.; Fago, G.; Marino, A. Trace analysis of estrogenic chemicals in sewage effluent using liquid chromatography combined with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2000, 14, 401–407.
Croley, T. R.; Hughes, R. J.; Koenig, B. G.; Metcalfe, C. D.; March, R. E. Mass spectrometry applied to the analysis of estrogens in the environment. Rapid Commun. Mass Spectrom. 2000, 14, 1087–1093.
Devanesan, P.; Todorovic, R.; Zhao, J.; Gross, M. L.; Rogan, E. G.; Cavalieri, E. L. Catechol estrogen conjugates and DNA adducts in the kidney of male Syrian golden hamsters treated with 4-hydroxyestradiol: Potential biomarkers for estrogen-initiated cancer. Carcinogenesis 2001, 22, 489–497.
Todorovic, R.; Devanesan, P.; Higginbotham, S.; Zhao, J.; Gross, M. L.; Rogan, E. G.; Cavalieri, E. L. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol. Carcinogenesis 2001, 22, 905–911.
Draisci, R.; Palleschi, L.; Ferretti, E.; Marchiafava, C.; Lucentini, L.; Cammarata, P. Quantification of 17β-estradiol residues in bovine serum by liquid chromatography-tandem mass spectrometry with atmospheric pressure chemical ionization. Analyst 1998, 123, 2605–2609.
Baronti, C.; Curini, R.; D’Ascenzo, G.; Di Corcia, A.; Gentili, A.; Samperi, R. Monitoring natural and synthetic estrogens at activated sludge sewage treatment plants and in a receiving river water. Environ. Sci. Technol. 2000, 34, 5059–5066.
Huang, C. H.; Sedlak, D. L. Analysis of estrogenic hormones in municipal wastewater effluent and surface water using enzyme-linked immunosorbent assay and gas chromatography/tandem mass spectrometry. Environ. Toxicol. Chem. 2001, 20, 133–139.
Kelly, C. Analysis of steroids in environmental water samples using solid-phase extraction and ion-trap gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry. J. Chromatogr. A 2000, 872, 309–314.
Shimada, K.; Mitamura, K.; Shiroyama, M.; Yago, K. Studies on neurosteroids. IX. Characterization of estrogens in rat brains using gas chromatography-tandem mass spectrometry. J. Chromatogr. A 1999, 847, 171–178.
Fournier, F.; Salles, C.; Tabet, J. C.; Debrauwer, L.; Rao, D.; Paris, A.; Borie, G. Tandem mass-spectrometric investigation on 17-β-estradiol palmitate in negative-ion chemical ionization. Anal. Chim. Acta 1999, 241, 265–272.
Ramanathan, R.; Cao, K.; Cavalieri, E.; Gross, M. L. Mass spectrometric methods for distinguishing structural isomers of glutathione conjugates of estrone and estradiol. J. Am. Soc. Mass Spec. 1998, 9, 612–619.
Embrechts, J.; Lemiere, F.; van Dongen, W.; Esmans, E. L. Equilenin-2′-deoxynucleoside adducts: Analysis with nano-liquid chromatography coupled to nano-electrospray tandem mass spectrometry. J. Mass Spectrom. 2001, 36, 317–328.
van Breemen, R. B.; Huang, C.-R.; Nikolic, D.; Woodbury, C. P.; Zhao, Y.-Z.; Venton, D. L. Pulsed ultrafiltration mass spectrometry: A new method for screening combinatorial libraries. Anal. Chem. 1997, 69, 2159–2164.
Zhao, Y.-Z.; van Breemen, R. B.; Nikolic, D.; Huang, C.-R.; Woodbury, C. P.; Schilling, A.; Venton, D. L. Screening solution-phase combinatorial libraries using pulsed ultrafiltration/electrospray mass spectrometry. J. Med. Chem. 1997, 40, 4006–4012.
Nikolic, D.; van Breemen, R. B. Screening for inhibitors of dihydrofolate reductase using pulsed ultrafiltration mass spectrometry. Comb. Chem. High Throughput Screen. 1998, 1, 47–55.
Nikolic, D.; Habibi-Goudarzi, S.; Corley, D. G.; Gafner, S.; Pezzuto, J. M.; van Breemen, R. B. Evaluation of cyclooxygenase-2 inhibitors using pulsed ultrafiltration mass spectrometry. Anal. Chem. 2000, 72, 3853–3859.
Liu, J.; Burdette, J. E.; Xu, H.; Gu, C.; van Breemen, R. B.; Bhat, K. P. L.; Booth, N.; Constantinou, A. I.; Pezzuto, J. M.; Fong, H. H. S.; Farnsworth, N. R.; Bolton, J. L. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J. Agric. Food Chem. 2001, 49, 2472–2479.
Obourn, J. D.; Koszewski, N. J.; Nortides, A. C. Hormone-and DNA-binding mechanisms of the recombinant human estrogen receptor. Biochemistry 1993, 32, 6229–6236.
Miksicek, R. J. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 1994, 49, 153–160.
Kassel, D. B.; Conster, T. G.; Shalaby, M.; Sekhri, P.; Gordon, N.; Nadler, T. In Techniques in Protein Chemistry. VI; Crabb, J. W., Ed.; Academic Press, San Diego, CA, 1995; p 39.
Zuckermann, R. N.; Kerr, J. M.; Siani, M. A.; Banville, S. C.; Santi, D. V. Identification of highest-affinity ligands by affinity selection from equimolar peptide mixtures generated by robotic synthesis. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 4505.
Schumacher, T. N. M.; Mayr, L. M.; Minor, D. L., Jr.; Milhollen, M. A.; Burgess, M. W.; Kim, P. S. Identification of D-peptide ligands through mirror-image phage display. Science 1996, 274, 1854–1857.
Liang, R.; Yan, L.; Leobach, J.; Ge, M.; Uozumi, Y.; Sekanina, K.; Horan, N.; Gildersleeve, J.; Thompson, C.; Smith, A.; Biswas, K.; Still, W. C.; Kahne, D. Parallel synthesis and screening of a solid phase carbohydrate library. Science 1996, 274, 1520–1522.
Liu, X.; Yao, J.; Pisha, E.; Yang, Y.; Hua, Y.; van Breemen, R. B.; Bolton, J. L. Oxidative DNA damage induced by equine estrogen metabolites: Role of estrogen receptor α. Chem. Res. Toxicol. 2002, 15, 512–519.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published online December 22, 2004
Rights and permissions
About this article
Cite this article
Sun, Y., Gu, C., Liu, X. et al. Ultrafiltration tandem mass spectrometry of estrogens for characterization of structure and affinity for human estrogen receptors. J Am Soc Mass Spectrom 16, 271–279 (2005). https://doi.org/10.1016/j.jasms.2004.11.002
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1016/j.jasms.2004.11.002